XBAH
542920
Market cap137bUSD
, Last price
INR
Name
Sumitomo Chemical India Ltd
Chart & performance
P/E
—
P/S
—
EPS
10.88
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
4.13%
Revenues
32.38b
+2.85%
Net income
5.43b
+7.41%
CFO
5.22b
+1.05%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sumitomo Chemical India Limited (SCIL) specializes in the global production and distribution of a diverse array of chemical products. Its core business encompasses the manufacture and sale of insecticides for household and public health use, agricultural crop protection agents, and animal nutritional supplements, catering to both Indian and international markets. The company's operations are structured into two primary segments: Agro Chemicals and other diversified offerings. SCIL's extensive product line includes a variety of crop protection solutions, such as insecticides, herbicides, fungicides, and miticides. Additionally, it provides plant growth regulators, animal nutrition products, pest control items like fumigants and rodenticides, weedicides, and various biological products. Established in 2000, Sumitomo Chemical India Limited is headquartered in Mumbai, India, and operates as a subsidiary of Sumitomo Chemical Company Limited.
Legal address
BLDG NO.1,GF,SHANT MANOR CO-OP HOUSING SOCIETY LTD CHAKRAVARTI ASHOK X ROAD,KANDIVLI (E)
MUMBAI, MH 400101
IN
MUMBAI, MH 400101
IN
Headquarters
13&14, ARADHANA INDUSTRIAL DEVELOPMENT CORPORATION NEAR VIRWANI INDUSTRIAL ESTATE, GOREGAON (EAST)
MUMBAI, MH 400063
IN
MUMBAI, MH 400063
IN
Valuation
Title INR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||